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The activating protein 1 (AP-1) family of regulatory proteins is characterized as immediate-early inducible
transcription factors which were shown to be activated by a variety of stress-related stimuli and to be involved
in numerous biological processes, including cellular and viral gene expression, cell proliferation, differentia-
tion, and tumorigenesis. We have recently demonstrated the involvement of the AP-1 family members c-Jun and
c-Fos in transcriptional regulation of the human polyomavirus, JC virus (JCV), genome. Here, we further
examined their role in JCV gene regulation and replication through their physical and functional interaction
with JCV early regulatory protein large T antigen (T-Ag). Transfection and replication studies indicated that
c-Jun and c-Fos can significantly diminish T-Ag-mediated JCV gene transcription and replication. Affinity
chromatography and coimmunoprecipitation assays demonstrated that c-Jun and T-Ag physically interact with
each other. Results from band shift assays showed that the binding efficiency of c-Jun to the AP-1 site was
reduced in the presence of T-Ag. In addition, we have mapped, through the use of a series of deletion mutants,
the regions of these proteins which are important for their interaction. While the c-Jun interaction domain of
T-Ag is localized to the middle portion of the protein, the T-Ag interacting domain of c-Jun maps to its
basic-DNA binding region. Results of transient-transfection assays with various c-Jun mutants and T-Ag
expression constructs further confirm the specificity of the functional interaction between c-Jun and T-Ag.
Taken together, these data demonstrate that immediate-early inducible transcription factors c-Jun and c-Fos
physically and functionally interact with JCV major early regulatory protein large T-Ag and that this inter-
action modulates JCV transcription and replication in glial cells.
The activating protein 1 (AP-1) family of transcription fac-
tors was shown to be involved in a wide variety of cellular
processes, including cell proliferation, cellular and viral gene
expression, cell death, survival, and differentiation, and tumor-
igenesis (52). In particular, c-jun knockout studies resulted in
an embryonically lethal phenotype. Furthermore, mouse em-
bryonic fibroblasts established from the c-Jun knockout mouse
showed severe proliferative defects and can be propagated
only once or twice before entering a premature senescence
(23). Biochemical purification showed that AP-1 is not a single
transcription factor but instead is a series of related dimeric
complexes of the Jun (c-Jun, JunB, and JunD) and Fos (c-Fos,
FosB, Fra-1, and Fra-2) families (4, 62). Each family member
is a phospho-nuclear protein and composed of three distinct
functional domains, including a carboxy-terminal leucine-zip-
per domain followed by an adjacent basic DNA binding do-
main and an amino-terminal transactivation domain. The fam-
ily members form homo- and heterodimers within the family
and outside the family with those factors that contain basic-
leucine zipper (bZIP) motifs, such as the CREB and ATF2
families (50). Dimerization occurs through leucine repeats that
are clustered proximally to the carboxy-terminal region. It is
interesting that unlike c-Jun family members, the Fos family
members form only heterodimers. DNA binding activity of
AP-1 is mediated by the basic DNA binding domain and occurs
in a hierarchical manner. Following dimerization, the specific
residues in the basic region (62) make base contacts with target
sequences on DNA, which are known as the 12-O-tetrade-
canoyl-13-phorbol acetate-response element (TGACTCA,
TRE). These sequences are present within the promoter re-
gions of many inducible genes (3, 58).
Transcriptional activity of this family of factors is regulated
by the N-terminal transactivation domain, largely in a phos-
phorylation-dependent manner. For example, phosphorylation
of serine63 and serine73 residues of c-Jun by the Jun N-ter-
minal kinase (JNK) family of kinases results in a large increase
in its ability to interact with the CBP/p300 family of cofactors
and, to a similar extent, in the transcriptional activation po-
tential of the protein (4, 62). AP-1 family members are induced
by a wide variety of signals, including, but not limited to, UV
light, ionizing radiation, oxidative stress, neuronal depolariza-
tion, cytokines (tumor necrosis factor , gamma interferon,
and interleukin-1), and viral infection (9, 13, 17, 18, 21, 50, 51,
63). They are collectively known as proto-oncogenes because
of their high sequence homology to some retroviral encoded
oncogenic proteins and their involvement in many cellular
processes, including cell proliferation, survival, and apoptosis
(8, 30, 50, 56, 62).
JC virus (JCV) is a human polyomavirus with a double-
stranded covalently linked circular genome and is the etiolog-
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ical agent of a fatal demyelinating disease, progressive multi-
focal leukoencephalopathy (PML), in immunocompromised
individuals (6). JCV lytically infects oligodendrocytes, the my-
elin-producing cells of the central nervous system, and utilizes
a clathrin-mediated pathway to enter the cells (31, 36, 61). The
viral genome is composed of regulatory and coding regions.
The regulatory region contains DNA target sequences for both
viral and cellular transcription factors, including NF-B (39,
45), Tst-1 (41, 60), NF-1 (1, 2, 35), Sp-1 (20), GBP-i (38), YB-1
(24, 44, 46, 48), and Pur (11, 46). The viral coding regions
encode early regulatory proteins (small t, large T, and isoforms
of early proteins, T) and late structural capsid proteins (VP-1,
VP-2, and VP-3). In addition to structural proteins, the leader
sequences of late transcripts also encode a basic regulatory
protein, Agnoprotein, which has been recently shown to play a
role in viral DNA replication and transcription (43, 48). Al-
though little is known about the function of small t antigen, the
large T antigen (T-Ag) was shown to be a multifunctional
phosphoprotein involved in both viral DNA replication (32–34,
54) and viral gene transcription (25, 29). Additionally, T-Ag is
oncogenic; its expression can lead to the induction of tumors of
neuronal origin in experimental animals (27, 53, 57), and its
genome has been detected in several human tumors (26, 28,
40). In addition, the several spliced variants of early proteins
were shown to differentially interact with the retinoblastoma
family of tumor suppressor proteins (14, 55).
JCV exhibits significant sequence homology (70%) to its
counterpart simian virus 40 (SV40) in coding regions (15), and
the early gene product, large T-Ag, for each virus displays
similar functions in viral DNA replication and transcription.
Previous studies indicated that SV40 large T-Ag cooperates
with c-Jun in down-regulation of myelin Po gene expression in
secondary Schwann cells (7). It was also demonstrated that
cells undergo apoptosis when SV40 T-Ag and c-Jun coex-
pressed in HaCat cells (12). In addition, we and other inves-
tigators demonstrated that c-Jun interacts with its target DNA
sequences present within the control region of JCV and posi-
tively regulates viral gene transcription (2, 42). Altogether,
these studies suggested the possibility of a functional interac-
tion between T-Ag and AP-1 family members such as c-Jun
and perhaps with other family members as well. In this report,
we used JCV as a model system and investigated the effect of
AP-1 family members c-Jun and c-Fos on JCV T-Ag-mediated
functions and provide experimental evidence that AP-1 family
members physically and functionally interact with JCV large
T-Ag and negatively affect both T-Ag-dependent viral gene
transcription and replication.
MATERIALS AND METHODS
Cell lines. U-87MG (ATCC HTB14), a human glioblastoma cell line, was
grown in Dulbecco’s modified Eagle’s medium supplemented with 10% heat-
inactivated fetal bovine serum and antibiotics (penicillin-streptomycin, 100 g/
ml) and was maintained at 37°C in a humidified atmosphere with 7% CO2.
HJC-15b cells (37) derived from hamster brain tumors (59) which were induced
by JCV were grown in Dulbecco’s modified Eagle’s medium supplemented with
10% heat-inactivated fetal calf serum and antibiotics (penicillin-streptomycin,
100 g/ml).
Plasmid constructs. The pBLCAT3-Mad-1L reporter construct containing the
regulatory region of JCV Mad-1 strain in the late orientation has been previously
described (11). Expression plasmids for RSV-c-Jun and RSV-c-Fos were kindly
provided by B. E. Sawaya (Temple University). pGEX2T-T-Ag (1-688) and its
deletion mutants, pGEX2T-T-Ag (1-411), pGEX2T-T-Ag (1-265), pGEX2T-
T-Ag (1-81), pGEX2T-T-Ag (266-688), pGEX2T-T-Ag (412-688), and
pGEX2T-T-Ag (629-688), were previously described (44). pGEX2T-c-Jun (1-
333) and its deletion mutants, pGEX2T-c-Jun (1-257), pGEX2T-c-Jun (1-150),
pGEX2T-c-Jun (1-151-333), pGEX2T-c-Jun (258-333), and pGEX2T-c-Jun
(281-333), were created by PCR amplification utilizing the following specific
primers.
The forward primers were c-Jun 5 (5-ATGACTGCAAAGATGGAAACG
ACCTTC-3), FP aa 258 (5-AAGCGCATGAGGAACCGCATC-3), FF aa 151
(5-ACTGCAAAGATGGAAACGACCTTC-3), and FF aa 281 (5-GAGGAA
AAAGTGAAAACCTTG-3). The reverse primers were c-Jun-3 (5-TCAAAA
TGTTTGCAACTGCTG-3), RP aa 280 (5TCACAGCCGGGCGATTCTCTC
CAG-3), RP aa 257 (5-TCACCATGTCAGTGGGGGACAGGG-3), and RP
aa 150 (5-TCACACCGAGGGTACCGCGGGAGC-3). RSV-c-Jun plasmid
was used as a template in PCR amplification. pGEX2T-c-Fos was created by
PCR amplification utilizing 5 primer (5-ATGTTCTGCGGCTTCAACGCAG
ACTAC-3) and 3 primer (5-TCACAGGGCCAGCAGCGTGGGTGAGCT-
3) by subcloning the PCR product into BamHI/EcoRI sites of pGEX2T vector.
RT-PCR-amplified human c-Fos cDNA was used as a template in PCR.
pcDNA3-HA-c-Jun (1-257) and pcDNA3-HA-c-Jun (258-333) expression plas-
mids were also created by PCR amplification. Corresponding regions were PCR
amplified and subcloned into BamHI/EcoRI sites of pcDNA3 and tagged with
hemagglutinin tag in-frame at the 5-end. CMV-T-Ag expression plasmid has
been previously described (10).
Reporter gene assays. A reporter construct containing the JCV regulatory
region in late (pBLCAT3-Mad-1L) orientation was transiently transfected into
U-87MG cells by the calcium-phosphate precipitation method (19) either alone
or in combination with c-Jun (RSV–c-Jun) and c-Fos (RSV–c-Fos) and JCV
T-Ag (CMV–T-Ag) expression plasmids. Plasmid concentrations used in each
transfection experiment are indicated in the text and/or in the respective figure
legends. The total amount of DNA transfected into the cells was normalized by
using respective empty vectors. A glycerol shock was applied at 3 h posttrans-
fection, and the medium was replenished. At 48 h posttransfection, cells were
lysed by freeze-thaw cycles. After clearance of cell debris, the protein concen-
tration of the supernatants was normalized, and CAT (chloramphenicol acetyl-
transferase) activity of samples was determined with 100 g of protein for each
sample. Transfections were repeated more than three times with different plas-
mid preparations. Standard deviations are indicated by error bars.
Replication assay. Replication assays were carried out as previously described
(47). Briefly, a replication-competent plasmid, pBLCAT3-Mad-1L, containing
the regulatory region of Mad-1 strain of JCV was transfected alone or in com-
bination with expression vectors CMV-T-Ag, RSV-c-Jun, RSV-c-Fos, CMV-c-
Jun (1-257), and CMV-HA-c-Jun (258-333) into U-87MG cells (0.4  106 cells
per 60-mm-diameter plate) with the calcium phosphate precipitation method.
Plasmid concentrations used in transfections are indicated in respective figure
legends, and the total amount of DNA transfected into the cells was normalized
with appropriate empty vectors. A glycerol shock was applied at 4 h posttrans-
fection, and the medium was replenished. At 72 h posttransfection, low-molec-
ular-weight DNA containing both input and replicated plasmids was isolated by
the Hirt method (22), digested with BamHI and DpnI enzymes, resolved on 1%
agarose gel, and analyzed by Southern blotting. The bands corresponding to the
replicated DNA were quantitated by utilizing a densitometer (Bio-Rad Fx Phos-
phorImager) with Quantity One Software. The degree of inhibition of T-Ag-
mediated JCV DNA replication by AP-1 was expressed as percent inhibition with
respect to the degree of viral DNA replication in the presence of T-Ag alone.
Nuclear extract preparation. Nuclear extracts from U-87MG (treated or un-
treated with UV) was prepared by a modification of the miniextract protocol, as
described by Schreiber et al. (49). UV-treated and untreated cells were harvested
by trypsinization, washed once with complete Dulbecco’s modified Eagle me-
dium and twice with phosphate-buffered saline (PBS), and transferred to an
Eppendorf tube. The cells were then resuspended in cold hypotonic buffer [10
mM N-2-hydroxyethylpipezine-N-2-ethanesulfonic acid (HEPES) (pH 7.9), 10
mM KCl, 0.1 mM EDTA, 0.1 mM ethylene glycol bis(-aminoethyl ether)-
N,N,N,N,-tetraacetic acid (EGTA), 1 mM dithiothreitol (DTT), 0.5 mM phe-
nylmethylsulfonyl fluoride (PMSF)] and allowed to swell on ice. Cellular mem-
branes were cleared by the addition of Nonidet P-40 (0.5% final concentration)
and vortexing. The nuclei were pelleted by centrifugation at 10,000  g, resus-
pended in cold extraction buffer (containing 20 mM HEPES [pH 7.9], 0.4 M
NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT and supplemented with a
cocktail of protease inhibitors), and extracted at 4°C for 15 min on a racking
platform. The nuclear extract was centrifuged, and the supernatant was frozen at
70°C.
Mobility band shift assay. Band shift assays were carried out as described
previously (46). Briefly, a double-stranded synthetic oligonucleotide containing
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JCV AP-1 binding site (5-CAAGCATGAGCTCATACCTA-3) was end la-
beled with [	-32P]ATP with T4 polynucleotide kinase and gel purified. Nuclear
extracts (10 g/lane) prepared from U-87MG cells, untransfected or transfected
with a JCV large T-Ag expression plasmid (CMV-T-Ag), were incubated with
labeled probe (40,000 cpm/lane) in a binding buffer containing 1.0 g of poly(dI-
dC), 12 mM HEPES (pH 7.9), 4 mM Tris (pH 7.5), 60 mM KCl, 5 mM MgCl2,
and 1.0 mM DTT. The reaction mixture was incubated at 4°C for 30 min to allow
assembly of DNA-protein complexes. Experimental conditions for competitive
band shift and antibody supershift assays are described under respective figure
legends. The complexes were resolved on a 6% polyacrylamide gel in 0.5 TBE
(1 TBE is 89 mM Tris-HCl [pH 8.0], 89 mM boric acid, and 2 mM EDTA [pH
8.0]). Gels were dried, and complexes were detected by autoradiography.
UV treatment. U-87MG cells were plated on 100-mm-diameter tissue culture
dishes and grown to subconfluence. Cells were then washed twice with PBS and
kept under a thin layer of PBS until treated with UV (254 nm, 40 J/m2). Cells
were subsequently incubated in fresh media and harvested 16 h posttreatment for
nuclear extract preparation.
In vitro transcription-translation assay. Full-length c-Jun was radiolabeled
with [35S]methionine by using a TNT coupled in vitro transcription-translation
system (Promega, Madison, Wis.) in accordance with the recommendations of
the manufacturer.
Coimmunoprecipitation and Western blot analysis. Two micrograms of anti-
c-Jun antibody (KM-1; Santa Cruz) or preimmune serum was incubated with 0.5
mg of nuclear extract prepared from U-87MG cells overnight at 4°C with con-
tinuous rocking. Immunocomplexes were precipitated with the addition of pro-
tein A-Sepharose beads (20 l of 50% slurry) (Pharmacia, Piscataway, N.J.) for
an additional 2 h and washed extensively with lysis buffer containing 20 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% NP-40, and a cocktail of protease
inhibitors. Immunocomplexes were then resolved by sodium dodecyl sulfate
(SDS)-10% polyacrylamide gel electrophoresis (PAGE) and transferred onto an
immunoblotting membrane. The blots were then probed with an anti-SV40 T-Ag
antibody (Ab-2 416) which cross-reacts with JCV T-Ag, developed with an ECL
detection kit (Amersham-Pharmacia, Piscataway, N.J.) in accordance with the
manufacturer’s recommendations, and analyzed for the presence of T-Ag.
GST affinity chromatography assays (GST pull-down). All glutathione S-
transferase (GST) and GST fusion proteins were expressed and purified as
described previously (48). For GST pull-down assays, 2 g of either GST alone
or GST–c-Jun or the deletion mutants of c-Jun immobilized on glutathione-
Sepharose beads were incubated with 0.2 mg of nuclear extract prepared from
U-87MG cells treated with UV overnight at 4°C in lysis buffer containing 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, and 0.5% Nonidet P-40 supplemented with a
cocktail of protease inhibitors (Sigma). Formed complexes were washed exten-
sively with lysis buffer and resolved by SDS-10% PAGE followed by Western blot
analysis with anti-Jun antibody (KM-1; Santa Cruz). Alternatively, 4 l of 35S-
labeled in vitro-translated full-length c-Jun was incubated with GST alone or
full-length GST–c-Jun fusion protein immobilized on glutathione-Sepharose
beads. All reactions were performed in 400 l of total reaction volume in lysis
buffer overnight at 4°C with continuous rocking. After incubation, the beads were
washed extensively with lysis buffer, and complexes were resolved by SDS-10%
PAGE. Gels were dried and analyzed for c-Jun by autoradiography. Similarly,
GST pull-down assays were also performed for GST–c-Fos fusion protein with
whole-cell extracts (0.2 mg) prepared from HJC cells constitutively expressing
JCV T-Ag utilizing anti-SV40 T-Ag antibody (Ab-2 416).
For mapping studies, 0.3 mg of whole-cell extract from HJC cells constitutively
expressing JCV T-Ag were incubated with GST, GST–c-Jun, or GST–c-Jun
amino- and carboxy-terminal deletion mutants immobilized on glutathione-
Sepharose beads. Bound complexes were washed with lysis buffer and analyzed
by Western blotting with anti-SV40 T-Ag antibody (Ab-2 416) for the detection
of T-Ag. In reciprocal mapping studies, nuclear extracts prepared from U-87MG
cells treated with UV were incubated with 2 g of GST, GST–T-Ag, or GST–
T-Ag amino- and carboxy-terminal deletion mutants immobilized on glutathio-
ne-Sepharose beads. Bound complexes were analyzed by Western blotting with
anti-c-Jun antibody (KM-1) for the detection of c-Jun. All reactions were per-
formed in 400 l of total reaction volume in lysis buffer overnight at 4°C with
continuous rocking.
RESULTS
AP-1 functionally interacts with large T-Ag. The members of
the AP-1 family of transcription factors are involved in regu-
lation of a wide range of cellular processes, including gene
activation and repression (52). It has been previously shown
that both c-Jun and SV40 large T-Ag are required for inhibi-
tion of Po gene promoter expression in secondary Schwann
cells (7). Additionally, the induction of apoptosis by SV40
T-Ag correlates with c-Jun overexpression (12), suggesting that
both proteins functionally interact with each other. Moreover,
our recent findings indicated that an AP-1 family member,
c-Jun, binds to its target sequences present within the regula-
tory region of JCV and regulates transcription from JCV early
and late promoters (42). Altogether, these observations sug-
gested the possibility that there would be a functional interac-
tion between these two proteins. To that end, U-87MG cells,
which support JCV transcription, were transiently transfected
with a reporter construct containing the JCV late promoter
alone or together with expression plasmids expressing either
c-Jun, c-Fos, or T-Ag transgenes. As shown in Fig. 1A, a CAT
reporter construct containing the JCV late promoter was
poorly expressed in U-87MG cells in the absence of transacti-
vators (lane 1). Cotransfection of the reporter construct with a
T-Ag expression plasmid, as expected, resulted in a substantial
(19.4-fold) increase in the transcriptional activity of the JCV
late promoter (29) (compare lanes 1 and 2). However, when a
constant amount of T-Ag was cotransfected with increasing
amounts of either c-Jun (lanes 3 and 4) or c-Fos (lanes 5 and
6) or a combination of c-Jun and c-Fos (lanes 7 and 8), we
observed a suppressive effect of c-Jun and c-Fos on the tran-
scriptional activity of the late promoter. Of note, expression
levels of T-Ag in the transfectants were analyzed by Western
FIG. 1. Effect of c-Jun and c-Fos on T-Ag-mediated transcription
from JCV late promoter. A reporter plasmid (7 g) containing the
JCV late gene promoter was transfected into U-87MG cells alone or
together with c-Jun (RSV-c-Jun), c-Fos (RSV-c-Fos), and T-Ag
(CMV-JCV T-Ag) expression plasmids, as described in Materials and
Methods. At 48 h posttransfection, cells were harvested and CAT
enzymatic activity of each transfectant was determined by using equal
100-g amounts of protein for each sample. Plasmid DNA concentra-
tions used in the transfection are indicated at the bottom of the panel
(in micrograms per 60-mm-diameter plate). Transfections were re-
peated several times with different plasmid preparations. Error bars
indicate the standard deviation for each sample. The data are repre-
sented as CAT activity relative to basal level expression of the pro-
moter.
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blotting, and results indicate that there appear to be equal
levels of T-Ag expression. Therefore, the observed reduction
in T-Ag-mediated activation of late promoter is not due to the
transfection efficiency of transfectants or apoptotic effect of
transactivators or the influence of c-Jun and c-Fos on CMV
promoter driving T-Ag expression in U-87MG cells (data not
shown). Altogether, these observations indicated that c-Jun
and c-Fos negatively affect the T-Ag-dependent activation of
JCV late promoter.
c-Jun and c-Fos suppress T-Ag-mediated viral DNA repli-
cation. T-Ag is a multifunctional phosphoprotein and is re-
quired for initiation of JCV DNA replication (15, 32, 33).
Transcriptional analysis of the JCV late promoter in the pres-
ence of c-Jun and c-Fos and T-Ag by cotransfection experi-
ments showed a functional interaction between these proteins.
We further investigated this functional interaction by employ-
ing a DpnI-DNA replication assay (10). A replication-compe-
tent plasmid containing the JCV origin of DNA replication was
transfected alone or in combination with expression plasmids
for c-Jun, c-Fos, and T-Ag into U-87MG cells. At 72 h post-
transfection, low-molecular-weight DNA was isolated by the
Hirt procedure (22) and newly replicated DNA was analyzed
by Southern blotting. As shown in Fig. 2, in the presence of
T-Ag, the plasmid containing the viral regulatory region was
efficiently replicated (lane 3). However, overexpression of ei-
ther c-Jun (lane 4) or c-Fos (lane 5) or c-Jun and c-Fos to-
gether (lane 6) significantly inhibited T-Ag-mediated viral
DNA replication. c-Jun or c-Fos proteins alone showed no
ability to induce viral DNA replication (lanes 7 and 8, respec-
tively). These findings indicate that the AP-1 family members
c-Jun and c-Fos can negatively affect T-Ag-induced replication
of JCV DNA, perhaps through their physical interaction with
T-Ag.
T-Ag inhibits c-Jun binding to its target sequences. Our
observations from functional assays suggested that c-Jun and
T-Ag may associate with each other and influence each other’s
activity. To investigate the mechanism(s) involved in these
observations, we performed electrophoretic mobility band shift
assays using both double-stranded 32P end-labeled probe (JCV
AP-1 WT, whose sequence is shown in the legend to Fig. 3)
and nuclear extracts prepared from U-87MG cells transfected
with a T-Ag expression plasmid. As demonstrated in Fig. 3A,
when JCV AP-1 probe was incubated with nuclear extracts
prepared from either untransfected cells (lane 2) or trans-
fected cells (lane 3), we observed the formation of two distinct
protein-DNA complexes, namely, a major complex and a mi-
nor complex with a slower migration property. It was surprising
that the intensity of the band for the minor complex formed
with nuclear extracts prepared from untransfected cells was
significantly higher (69.3%) (lane 2) by densitometric analysis
than that formed with extracts from transfected cells (lane 3),
suggesting that T-Ag may interfere with the ability of c-Jun to
efficiently interact with its target sequences on DNA. We have
repeated these experiments with different nuclear extract prep-
arations and observed similar results (data not shown). The
specificity of observed complexes was further investigated by
competitive band shift and antibody supershift experiments.
Addition of the unlabeled JCV AP-1 oligonucleotide to the
reaction mixture abolished the formation of minor bands and
significantly decreased the efficiency of the protein-DNA com-
plex formation for the major band (lanes 4 and 5). In contrast,
unlabeled mutant JCV AP-1 oligonucleotide had no effect on
both complexes. The nature of these complexes was further
examined by antibody supershift experiments. Addition of pre-
immune antisera (lane 8) to the reaction mixture failed to show
any effect on the formation of either band. However, anti-c-Jun
antibody completely supershifted the minor band complex yet
had no effect on the formation of the major protein-DNA
complex, indicating that the observed minor complex is specific
for c-Jun binding. Figure 3B demonstrates the analysis of T-Ag
expression in transfected cells by Western blotting. Taken to-
gether, the results from band shift assays indicate that T-Ag
interferes with c-Jun binding to its target sequences.
c-Jun and c-Fos physically associate with T-Ag. Results
from both functional and band shift assays indicated that c-Jun
and c-Fos may in fact physically interact with JCV large T-Ag.
To test this possibility, we performed affinity chromatography
(GST pull-down) experiments in which one of the two proteins
was bacterially expressed as a GST fusion protein and bound to
FIG. 2. Both c-Jun and c-Fos inhibit T-Ag-mediated JCV DNA
replication. A replication-competent plasmid, pBLCAT3-Mad-1L (5
g), containing the regulatory region of the Mad-1 strain of JCV was
transfected alone or in combination with c-Jun (RSV-c-Jun), c-Fos
(RSV-c-Fos), and T-Ag (CMV JCV T-Ag) expression plasmids into
U-87MG cells, as described in Materials and Methods. Plasmid DNA
concentrations used in transfections are indicated on top (in micro-
grams per 60-mm-diameter plate). The total amount of DNA trans-
fected into the cells was normalized with appropriate empty vectors. At
72 h posttransfection, low-molecular-weight DNA was isolated by the
Hirt method (22), digested with both BamHI and DpnI enzymes, and
analyzed by Southern blotting. The bands corresponding to the repli-
cated DNA bands were quantitated by a densitometric method (see
Materials and Methods) and expressed as percent inhibition with re-
spect to the viral DNA replication in the presence of T-Ag alone.
Representative data for the DpnI assay are shown, and variability
among different experimental data is indicated by standard deviation.
In lane 1, pBLCAT3-Mad-1L plasmid linearized with BamHI enzyme
digestion was loaded as a control. The results are represented as
percent inhibition and are shown at the bottom. The variability be-
tween different replication assays is indicated by standard deviation.
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a glutathione resin, while the other protein was passed over the
resin and analyzed for its ability to be specifically retained by
the GST fusion protein. GST or GST–T-Ag fusion protein was
immobilized on glutathione-Sepharose beads and incubated
with nuclear extracts prepared from U-87MG cells either non-
treated or treated with UV, which is known to potently induce
c-Jun upregulation and phosphorylation (4, 62). Protein com-
plexes bound to GST or GST–T-Ag were washed extensively
and analyzed by Western blotting with an anti-c-Jun antibody,
which detects both phosphorylated and nonphosphorylated
forms of c-Jun on Western blots. As shown in Fig. 4A, surpris-
ingly, both phosphorylated and nonphosphorylated forms of
c-Jun protein are retained on the Sepharose column containing
GST–T-Ag fusion protein (lane 4), indicating that both forms
of c-Jun are capable of interacting with T-Ag in vitro. An
interaction of this type between GST alone and c-Jun was not
observed (lane 3), which indicates the specificity of association
of c-Jun with T-Ag.
A similar GST pull-down assay was performed to demon-
strate the association of c-Fos with T-Ag. Whole-cell extracts
from hamster glial HJC-15b cells, constitutively expressing
T-Ag (37, 59), were incubated with either GST or GST–c-Fos,
and after washing, protein complexes retained in the columns
were analyzed by Western blotting with an anti-SV40 T-Ag
antibody (Ab-2 416). As demonstrated in Fig. 4B, T-Ag protein
from whole-cell extracts was retained in the GST–c-Fos gluta-
thione column (lane 3) but not in the GST column (lane 2),
indicating the specificity of interaction between c-Fos and
T-Ag.
We also investigated the protein-protein interaction be-
tween c-Jun and T-Ag by using a cell-free system. As shown in
Fig. 4C, in vitro-transcribed and translated full-length c-Jun
specifically and strongly interacts with GST–T-Ag fusion pro-
tein (lane 2) but not GST alone (lane 2) in a GST-pull-down
assay, further confirming the observed interaction between c-
Jun and T-Ag.
Next, to further examine the association of c-Jun with T-Ag,
we performed coimmunoprecipitation experiments. Nuclear
extracts prepared from HJC-15b cells were immunoprecipi-
tated either with normal serum (control) or an anti-c-Jun an-
tibody, and immunocomplexes were analyzed by Western blot-
ting for the presence of T-Ag with an anti-T-Ag antibody. Of
note, in addition to expressing large T-Ag, HJC-15b cells also
express high levels of c-Jun constitutively. As demonstrated in
Fig. 4D, T-Ag was coimmunoprecipitated with c-Jun and was
detected by the anti-T-Ag antibody (lane 3). The specificity of
this coimmunoprecipitation was verified when protein extracts
from HJC-15b cells were incubated with normal mouse serum
where no apparent coimmunoprecipitation of T-Ag was de-
tected (lane 2). Expression of c-Jun in HJC-15b cells was ver-
ified by Western blotting (data not shown). Altogether, our
findings from in vitro protein-protein interaction experiments
FIG. 3. T-Ag inhibits c-Jun binding to its target sequences in an electrophoretic mobility shift assay. (A) Band shift assay. A double-stranded
synthetic oligonucleotide containing JCV AP-1 binding site (5-CAAGCATGAGCTCATACCTA-3) spanning nucleotides 155 to 162 of JCV
Mad-1 regulatory region was end labeled with [	-32P]ATP with T4 polynucleotide kinase and gel purified. Nuclear extracts (10 g/lane) prepared
from U-87MG cells and untransfected (lane 2) or transfected with a T-Ag expression plasmid (lane 3) were incubated with labeled probe (40,000
cpm/lane) in a binding buffer, as described in Materials and Methods. In addition, probe plus nuclear extract from T-Ag-transfected cells was also
incubated with either unlabeled wild-type oligonucleotide (WT) (lanes 4 and 5) or 25- or 150-fold molar excesses of its mutant variant competitor
oligonucleotides (Mut) (5-CAAGCATTAGCTTGTACCTA-3; bold indicates base substitutions relative to the wild type) (lanes 6 and 7,
respectively). Probe plus nuclear extract mixture was also incubated either with a preimmune (-pre; 2 g) (lane 8) or an anti-c-Jun (-c-Jun,
KM-1; 2 g) (lane 9) antibody. Formed DNA-protein complexes were then resolved on a 6% polyacrylamide gel under native conditions and
visualized by autoradiography. The specific DNA-protein complexes are indicated by an arrow, and nonspecific complexes are indicated by a solid
arrowhead. A bracket indicates antibody supershifted complexes. (B) Western blot analysis. Nuclear extracts prepared from either untransfected
U-87MG cells (lane 1) or U-87MG cells transfected with CMV-T-Ag expression plasmid (lane 2) were analyzed by Western blotting using an
anti-SV40 T-Ag antibody (Ab-2 416) which is cross-reactive with JCV T-Ag. Comp, competitor; Ab, antibody; Tfxn, transfection.
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demonstrated that the AP-1 family members c-Jun and c-Fos
physically associate with T-Ag.
Mapping of T-Ag interaction domain of c-Jun. In the next
series of experiments, we attempted to map the region(s) of
c-Jun that are involved in the interaction with T-Ag. A series of
deletion mutants of the c-Jun gene was created, and mutant
c-Jun proteins fused to GST were incubated with whole-cell
lysate from HJC-15b cells. Bound complexes were resolved by
SDS-PAGE and analyzed by Western blotting with anti-T-Ag
antibody. As shown in Fig. 5A, as expected, GST–c-Jun full-
length protein (lane 3), but not GST alone (lane 2), efficiently
binds to T-Ag. However, removal of the carboxy-terminal re-
gion of c-Jun spanning amino acid residues 258 to 333 (lane 4),
151 to 333 (lane 5), and 281 to 333 (lane 8) completely abol-
ished the interaction between c-Jun and T-Ag. However, de-
letion of the amino-terminal region spanning residues 1 to 150
(lane 6) and 1 to 257 (lane 7) enhanced the binding ability of
T-Ag to c-Jun in comparison to that observed with full-length
c-Jun (compare lanes 6 and 7 to lane 3), suggesting that amino
acid residues between positions 1 and 257 have a negative
effect on the interaction between c-Jun and T-Ag. It is of note
that T-Ag expressed in HJC-15b cells exists as several isoforms,
depending on the phosphorylation state of the protein (37).
Interestingly, c-Jun interacts with all isoforms of T-Ag ex-
pressed in HJC-15b cells. This is similar to the previously
reported interaction of T-Ag with Pur and YB-1 (16, 44).
Taken together, these mapping studies demonstrate that the
T-Ag interaction domain of c-Jun is localized to amino acid
residues between positions 258 and 280, which overlap with a
portion of the basic-DNA binding domain of c-Jun protein,
suggesting that T-Ag, by binding to the DNA binding domain
of c-Jun, may interfere with its binding to DNA and therefore
with its transcriptional activity. These findings correlate with
our band shift assays (Fig. 3A) in which we observed that T-Ag
negatively affects the DNA binding activity of c-Jun to its target
sequences (Fig. 3A). Figure 5B illustrates the Coomassie blue-
stained SDS-PAGE of the full-length and mutant proteins
which were used in this study and verifies the integrity of the
protein preparations. Figure 5C summarizes the results of the
GST pull-down assay and depicts the regions of c-Jun that bind
to T-Ag.
Localization of c-Jun interaction domain of T-Ag. To iden-
tify the protein domain(s) of T-Ag which confers the interac-
tion with c-Jun, a series of T-Ag carboxy-terminal and amino-
terminal deletion mutants fused with GST were prepared and
incubated with nuclear extracts prepared from U-87MG cells
treated with UV. In agreement with the results presented in
Fig. 4A, GST–T-Ag, but not GST, bound to both nonphospho-
rylated and phosphorylated forms of c-Jun (Fig. 6A, lanes 4
and 3, respectively). The binding activities of two carboxy-
terminal deletion mutants were slightly reduced, compared to
that of the full-length protein, when the residues between
positions 412 and 688 (lane 5) and 266 and 688 (lane 6) were
deleted. Similarly, the removal of the amino acids 1 to 265
(lane 8) and 1 to 411 (lane 9) further decreased the binding
efficiency of amino-terminal deletion mutants of T-Ag. The
remaining two deletion mutants retaining residues 1 to 81
(lane 7) and 629 to 688 (lane 10) showed no c-Jun binding
activity. Taken together, these mapping experiments demon-
strate that the c-Jun interaction domain of T-Ag lies within the
middle portion of the protein spanning amino acid residues 82
to 628. Figure 6B illustrates the Coomassie blue-stained SDS-
PAGE gel of the full-length T-Ag and T-Ag mutants which
were used in this study. A scheme for these observations is
shown in Fig. 6C.
Effect of two c-Jun mutant proteins on T-Ag-mediated gene
transcription and replication. To further assess the functional
interaction between c-Jun and T-Ag, we examined the ability
of mutant c-Jun proteins, which have retained or lost their
ability to interact with T-Ag in GST pull-down assays. We
chose mutant c-Jun (258-333), which had the ability to strongly
interact with T-Ag in in vitro GST pull-down assays, and mu-
tant c-Jun (1-257), which showed no T-Ag binding activity.
Transient-transfection assays were performed by utilizing a
reporter JCV late CAT construct and expression plasmids for
FIG. 4. Both c-Jun and c-Fos physically interact with T-Ag. (A) c-
Jun associates with T-Ag in GST pull-down assays. Nuclear extracts
(0.5 mg) prepared from U-87MG cells treated with UV and incubated
with either GST alone (lane 3) or GST–T-Ag (lane 4), both of which
are already immobilized on GST beads. After being washed extensively
with incubation buffer, proteins interacting with GST or GST–T-Ag
were analyzed by Western blotting with an anti-c-Jun antibody, KM-1,
which detects nonphosphorylated and phosphorylated forms of c-Jun.
Nuclear extracts prepared from nontreated U-87MG cells (lane 1) or
U-87MG cells treated with UV (lane 2) were loaded as negative and
positive controls, respectively (20 g/lane). Phosphorylated (c-Jun-P)
and nonphosphorylated (c-Jun) forms of c-Jun are indicated by arrows.
(B) Similarly, whole-cell extracts (0.2 mg) prepared from HJC cells
constitutively expressing JCV T-Ag were incubated with either GST
alone (lane 2) or GST–c-Fos (lane 3), and after being washed, proteins
interacting with GST or GST–c-Fos were analyzed by Western blotting
with an anti-SV40 T-Ag antibody, Ab-2 416, which is also cross-reac-
tive with JCV T-Ag. Whole-cell extract (10 g/lane) from HJC cells
was loaded as a positive control (lane 1). T-Ag is indicated by a
bracket. (C) In vitro-translated [35S]methionine-labeled c-Jun (IVT-c-
Jun) interacts with GST–T-Ag in a cell-free system. In vitro-labeled
full-length c-Jun was incubated with either GST (lane 2) or GST–T-Ag
fusion protein (lane 3). After extensive washing of the column with
binding buffer, bound proteins were resolved by SDS-10% PAGE and
analyzed by autoradiography. A small portion of IVT-c-Jun was loaded
as a positive control (lane 1). (D) T-Ag coimmunoprecipitates with
c-Jun. Coimmunoprecipitation experiments were performed as de-
scribed in Materials and Methods. Antibodies used for respective lanes
are shown at the top. An arrowhead points to the large subunit of
-c-Jun immunoglobulin G antibody used in immunoprecipitation as-
says. The positions of the molecular mass markers (in kilodaltons) are
shown on the left side of each panel.
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mutants c-Jun (258-333) and c-Jun (1-257). As shown in Fig.
7A, mutant c-Jun protein (258-333), which binds to T-Ag more
efficiently than full-length protein (Fig. 5A, lane 7), showed a
drastic negative effect on the T-Ag-mediated transcriptional
activation of the JCV late promoter (Fig. 7A) compared to
full-length protein (Fig. 1A, lanes 3 and 4). Under similar
conditions, however, mutant c-Jun protein (1-257), which does
not interact with T-Ag, had virtually no significant effect on the
level of transcriptional activation of the JCV late promoter by
T-Ag (Fig. 7B).
We also examined the effects of these two mutants [c-Jun
(1-257) and c-Jun (258-333)] on T-Ag-induced JCV DNA rep-
lication. In agreement with the above observations from trans-
fection assays, c-Jun (258-333) strongly inhibited T-Ag-medi-
ated JCV DNA replication (Fig. 7C). The mutant protein
c-Jun (1-258) showed no appreciable inhibitory or stimulatory
activity on the replication of viral DNA in glial cells (Fig. 7D).
Interestingly, comparison of the results from the studies re-
garding the effect of full-length c-Jun on T-Ag-mediated tran-
scription (Fig. 1A) with that obtained with mutant c-Jun (258-
333) (Fig. 7A) suggests that the mutant c-Jun protein (258-333)
is more potent in modulating T-Ag function than the full-
length protein. These findings corroborate the results obtained
from protein-protein interaction studies (Fig. 5A), where we
observed that c-Jun (258-333) displayed stronger binding ac-
tivity for T-Ag than the full-length protein. It should also be
noted that the expression of c-Jun mutants in these transfec-
tion assays was demonstrated by Western blot analysis (data
not shown), and therefore the absence of a functional interac-
tion between c-Jun and T-Ag may not be attributed to its lack
of expression in transfected cells. Taken together, the data
from functional assays utilizing c-Jun mutants, one of which,
c-Jun (258-333), physically and functionally interacts with
T-Ag, and the other, c-Jun (1-257), which lacks such charac-
teristics, further confirm the significance of interaction be-
tween c-Jun and T-Ag.
DISCUSSION
In this report, we examined the molecular mechanism(s)
involved in the regulation of JCV gene transcription and rep-
lication by the AP-1 family members c-Jun and c-Fos and by
the viral protein T-Ag; we showed that both c-Jun and c-Fos
FIG. 5. Localization of c-Jun domains important for interaction with T-Ag. (A) Whole-cell extracts prepared from HJC-15b cells (0.25 mg)
were incubated with either GST alone (lane 2), GST–c-Jun (lane 3), or deletion mutants of c-Jun fused to GST (lanes 4 to 8) (2 g each) which
were immobilized on glutathione-Sepharose beads. The Sepharose beads were washed extensively, and bound proteins were resolved by SDS–10%
PAGE, transferred onto nitrocellulose membrane, and detected with an anti-SV40 T-Ag antibody (Ab-2 416). (B) SDS–10% PAGE analysis of
GST, GST–T-Ag, and T-Ag deletion mutants. In lane 1, 10 g of whole-cell extract from HJC-15b cells was loaded as positive control.
(C) Summary of the results obtained from mapping assays. A schematic representation of c-Jun is shown at the top (not to scale). The abilities
of c-Jun and its deletion mutants to interact with T-Ag are shown on the right. , very strong interaction; , strong interaction; , reduced
or weak interaction; , no interaction.
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interact with T-Ag and negatively regulate T-Ag-mediated vi-
ral gene transcription and replication.
The members of the AP-1 family of transcription factors are
known to regulate transcription from many cellular and viral
promoters and are implicated in many important cellular and
viral processes, including gene transcription. It has been re-
ported recently that a member of the AP-1 family, c-Jun, spe-
cifically interacts with the target DNA binding sequences
present within the control region of JCV and regulates tran-
scription from JCV promoters (42). However, it was interest-
ing to observe in this study that c-Jun and c-Fos, individually or
in combination, negatively regulate T-Ag-dependent viral gene
transcription and replication (Fig. 1 and 2). Consistent with
this observation, the previous reports showed that Jun coop-
erates with SV40 virus large T-Ag in down-regulation of myelin
Po gene expression in secondary Schwann cells in vitro (7).
These observations suggested the possibility that c-Jun and
c-Fos may form a complex with T-Ag which is functionally
inactive in nature. With respect to this notion, we also ob-
served that in the presence of T-Ag, DNA binding activity of
c-Jun is diminished compared to normal levels in band shift
assays (Fig. 3). We also carried out in vitro protein-protein
interaction studies, including coimmunoprecipitation and GST
pull-down assays, to support the findings from band shift assays
and provided evidence that c-Jun and T-Ag in fact physically
interact with each other (Fig. 4A, B and C). In addition, it was
also evident from GST pull-down assays that the phosphory-
lated form of c-Jun is as capable of interacting with T-Ag as the
nonphosphorylated form. It was previously shown that AP-1
family members are phosphorylated upon induction by a vari-
ety of extracellular stimuli, including UV and viral infection,
and that phosphorylated forms are more active in terms of
their transcriptional activity (5, 62).
In addition to performing protein-protein interaction studies
to demonstrate physical interaction between c-Jun and T-Ag,
we also carried out experiments to map the domain(s) of the
interaction of these proteins with each other. The interaction
domain of c-Jun with T-Ag maps to the basic DNA binding
domain of the protein, which is juxtaposed with the leucine-
rich dimerization domain of the protein. This is an important
finding in light of our observations from functional assays, and
this interaction appears to interfere with the DNA binding and
therefore with transcriptional activity of c-Jun. It is known that
the DNA binding activity of the AP-1 family of transcription
factors is a prerequisite for their transcriptional activity. Re-
sults from DNA binding studies (Fig. 3) corroborate our find-
ings from mapping studies in that T-Ag interacts with DNA
binding domain of c-Jun and interferes with its association with
DNA. It is also important to note that T-Ag, which is consti-
tutively expressed in HJC-b15 cells, exists as several isoforms,
depending on the phosphorylation state of the protein, and all
isoforms are capable of interacting with c-Jun. Interestingly,
the phosphorylation state of T-Ag does not appear to dictate
the association between c-Jun and T-Ag, since bacterially ex-
pressed T-Ag, which does not contain phosphorylated resi-
dues, is able to interact with c-Jun (Fig. 6A). Nonetheless,
further experiments will be required to demonstrate the con-
tribution, if any, of the phosphorylation state of T-Ag to the
efficiency of formation of the intermolecular complex between
c-Jun and T-Ag. It was also interesting to observe that as the
amino-terminal sequences of c-Jun were deleted, the binding
efficiency of c-Jun deletion mutants (258-333) and (281-333)
(Fig. 5A, lanes 6 and 7) significantly improved, implying that
the sequences located within the amino-terminal region of
c-Jun may negatively regulate the protein-protein interaction
observed between c-Jun and T-Ag. Consistent with these ob-
servations, the use of c-Jun mutant (258-333) in transfection
studies (Fig. 7A) showed that this mutant is capable of sup-
pressing the T-Ag-mediated viral late gene transcription more
drastically than full-length c-Jun (compare lanes 3 and 4 in Fig.
7A with those in Fig. 1). Moreover, the results from in vitro
mapping experiments demonstrated that the c-Jun interaction
domain of T-Ag is localized to its central region (Fig. 6A),
which encompasses functionally important domains, including
the polymerase , ATP binding, ATPase, and helicase do-
mains. This suggests that c-Jun may interfere with those func-
tions by sequestering T-Ag in cells. Consistent with this hy-
pothesis, our findings from viral DNA replication studies
indicate that c-Jun, by binding to the central region of T-Ag,
may interfere with its function (Fig. 2 and 6C) in viral DNA
replication.
Transcriptional and replicational regulation of JCV involve
a highly organized cascade of events that requires participation
of both viral and cellular factors. The combination of cooper-
ative and antagonistic regulatory activities of both viral and
cellular transcription factors determines a successful outcome
of the viral productive cycle. At the initial stages of viral in-
fection, only host cellular factors are responsible for expression
of viral early genes in the absence of the viral large T-Ag.
When expressed, JCV large T-Ag in cooperation with cellular
factors initiates viral DNA replication and transactivates viral
late genes. In the early stages of infection cycle, the immediate-
early inducible genes, including the c-Jun and c-Fos genes,
which were shown to be induced by viral infection (17), are
likely to participate in regulation of JCV early promoter. Con-
sistent with this hypothesis, we have recently demonstrated
that the AP-1 family members c-Jun and c-Fos activate tran-
scription from JCV early promoter more strongly than from
late promoter (42). In this report, we further investigated the
regulatory function of AP-1 family members, in particular c-
FIG. 6. Mapping of interaction domain of T-Ag with c-Jun. (A) Nuclear extracts (0.2 mg) prepared from U-87MG cells treated with UV were
incubated with either GST alone (lane 3), GST–T-Ag (lane 4), or deletion mutants of GST–T-Ag fusion proteins (lanes 5 to 10) immobilized on
glutathione-Sepharose beads. Bound proteins were washed extensively, resolved by SDS–10% PAGE, and analyzed by Western blotting with an
anti-T-Ag antibody (Ab-2 416). C-Jun-P indicates the phosphorylated form of c-Jun. Nuclear extracts from nontreated U-87MG cells (lane 1) and
U-87MG cells treated with UV (lane 2) were loaded as positive controls. (B) Analysis of the GST and GST–T-Ag proteins and GST–T-Ag deletion
mutants by SDS–10% PAGE. (C) Summary of the binding assays. Upper portion, schematic representation of T-Ag with various functional
domains and binding regions for different proteins. Lower portion, the ability of T-Ag and its deletion mutants to interact with c-Jun is depicted.
, very strong interaction; , strong interaction; , reduced interaction; , no interaction.
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Jun and c-Fos, through their physical and functional interac-
tion with JCV regulatory protein large T-Ag and presented
evidence that both proteins display negative effects on T-Ag-
mediated viral gene transcription and replication. The physio-
logical consequence(s) of this negative regulation by AP-1 is
currently unknown. However, one can hypothesize that the
immediate-early inducible factors, including c-Jun and c-Fos,
although displaying positive regulatory roles on the expression
of JCV promoters in the absence of T-Ag and at the early
phases of infection, may exhibit antagonistic effects on T-Ag-
mediated activities during the late phases of infection. This
negative regulatory activity by AP-1 may result in a positive
effect on viral growth. AP-1 may prolong the survival of in-
fected cells by slowing down both JCV transcription and rep-
lication and therefore may positively influence the process of
maturation of the infectious viral particles. The study of JCV
regulatory processes at the molecular level will shed more light
on the molecular mechanisms governing the JCV-host inter-
actions and thereby pave the way to understand the progres-
sion of the diseases associated with JCV infections.
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